These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 7500909)

  • 1. Intravenous amiodarone.
    Med Lett Drugs Ther; 1995 Dec; 37(963):114-5. PubMed ID: 7500909
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
    Van Herendael H; Dorian P
    Vasc Health Risk Manag; 2010 Aug; 6():465-72. PubMed ID: 20730062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone for ventricular tachycardia after coronary artery bypass grafting.
    Wood MK
    Ann Thorac Surg; 1996 Jun; 61(6):1874. PubMed ID: 8651814
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical utility and adverse effects of amiodarone therapy.
    Roberts M
    AACN Adv Crit Care; 2010; 21(4):333-8; quiz 339-40. PubMed ID: 21045568
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proarrhythmic potential of amiodarone: an underestimated risk?
    Jurado Román A; Rubio Alonso B; Martín Asenjo R; Salguero Bodes R; López Gil M; Arribas Ynsaurriaga F
    Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):292-4. PubMed ID: 21813228
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am J Cardiol; 1999 Nov; 84(9A):46R-51R. PubMed ID: 10568659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone: the AHA's new drug of choice for victims of ventricular arrhythmias.
    Erich J
    Emerg Med Serv; 2000 Oct; 29(10):22. PubMed ID: 11140049
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular arrhythmias and the use of antiarrhythmic drugs after cardiovascular surgery.
    Olshansky B
    Am J Manag Care; 1998 Nov; 4(11):1603-10; quiz 1611-12. PubMed ID: 10338906
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias.
    Naccarelli GV; Jalal S
    Circulation; 1995 Dec; 92(11):3154-5. PubMed ID: 7586296
    [No Abstract]   [Full Text] [Related]  

  • 12. Amiodarone induced thrombophlebitis.
    Showkathali R; Earley MJ; Sporton S
    Emerg Med J; 2006 Aug; 23(8):660. PubMed ID: 16858113
    [No Abstract]   [Full Text] [Related]  

  • 13. Amiodarone administration for refractory ventricular fibrillation or pulseless ventricular tachycardia.
    Rosini JM; Zizza L
    Nursing; 2016 Oct; 46(10):61-2. PubMed ID: 27654444
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence-based analysis of amiodarone efficacy and safety.
    Connolly SJ
    Circulation; 1999 Nov; 100(19):2025-34. PubMed ID: 10556230
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of amiodarone in the management of patients with cardiac arrest.
    Franks AM; Watterson KS
    J Ark Med Soc; 2000 Dec; 97(6):196-9. PubMed ID: 12876823
    [No Abstract]   [Full Text] [Related]  

  • 16. Overview of trends in the control of cardiac arrhythmia: past and future.
    Singh BN
    Am J Cardiol; 1999 Nov; 84(9A):3R-10R. PubMed ID: 10568654
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias.
    Nolan PE
    Pharmacotherapy; 1997; 17(2 Pt 2):65S-75S; discussion 89S-91S. PubMed ID: 9085342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amiodarone-induced thyroid gland dysfunctions].
    Gassanov N; Dietlein M; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Apr; 135(16):807-11. PubMed ID: 20391312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous amiodarone.
    Kowey PR; Marinchak RA; Rials SJ; Filart RA
    J Am Coll Cardiol; 1997 May; 29(6):1190-8. PubMed ID: 9137212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.